Long Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) announced prescription trend data this morning for its primary revenue driver, H.P. Acthar Gel (Acthar), and the news is positive, sending the … Continue Reading
Read NowLong Ideas - Delcath Systems (NADSAQ:DCTH) continues to trade well-above average volume Tuesday, ahead of the FDA’s decision on the company’s recently submitted New Drug Application (NDA) for … Continue Reading
Read NowLong Ideas - By Jake King Spectrum Pharmaceuticals (NASDAQ:SPPI) announced Monday morning that the company received a five-year extension on its patent for Folotyn, which lengthens the drug’s … Continue Reading
Read NowLong Ideas - Breaking news that health insurer, Oxford Health, will cover HP Acthar Gel (Acthar), looks like a major win for Questcor Pharmaceuticals (NASDAQ:QCOR), and the stock … Continue Reading
Read NowLong Ideas - By David Moskowitz Sunesis Pharmaceuticals (NASDAQ:SNSS) is getting the benefit of a price target increase this morning; Roth Capital raised its price target on the … Continue Reading
Read NowLong Ideas - Endo Pharmaceuticals (NASDAQ:ENDP) is hosting its analyst day today in NY, and despite guiding for lower 2013 revenues and EPS compared to Wall Street Consensus … Continue Reading
Read NowLong Ideas - By David Moskowitz Sunesis Pharmaceuticals (NASDAQ:SNSS) has had a great year thus far, up 350% since January, and importantly, the smart money continues to flock … Continue Reading
Read Now